Molecular_characterization_of_a_supratypic_cross-reactive_idiotype_associated_with_IgM_autoantibodies._Neoplastic_B_cells_from_patients_with_chronic_lymphocytic_leukemia_(CLL)_or_small_lymphocytic_lymphomas_(SLL)_frequently_express_surface_Ig_reactive_with_the_mouse_mAb,_Lc1._Raised_against_a_human_monoclonal_IgM_with_rheumatoid_factor_activity,_Lc1_detects_a_major_cross-reactive_Id_(CRI)_present_on_the_H_chain_of_many_monoclonal_IgM_autoantibodies._In_contrast_to_other_major_autoantibody-CRI_investigated_to_date,_we_note_that_the_Lc1-CRI_is_expressed_by_subpopulation_of_cells_in_the_germinal_centers,_as_well_as_in_the_mantle_zones,_of_secondary_human_B_cell_follicles._To_examine_the_molecular_basis_for_Lc1_expression,_we_used_the_polymerase_chain_reaction_to_isolate_the_functionally_rearranged_Ig_VH_genes_of_monoclonal_Lc1-reactive_B_cell_populations_from_six_unrelated_patients_with_CLL_or_SLL._Although_the_neoplastic_B_cells_from_most_patients_with_CLL_or_SLL_express_the_CD5_surface_differentiation_Ag,_the_lymphoma_cells_from_one_patient_with_SLL_were_CD5-negative._We_find_that_the_Lc1-reactive_cells_from_each_cell_population_have_Ig_rearrangements_involving_a_VH_gene_of_the_VH4_subgroup._However,_the_VH4_genes_rearranged_in_different_Lc1-reactive_tumor_populations_may_originate_from_at_least_two_disparate_germ-line_VH4_genes._Also,_in_contrast_to_the_CD5-positive_tumor_populations,_we_find_evidence_for_intraclonal_diversity_in_the_functionally_rearranged_VH4_genes_of_the_CD5-negative_SLL._Collectively,_this_study_discerns_a_degeneracy_in_the_VH4_genes_that_can_encode_the_Lc1_CRI,_indicating_the_term_"supratypic_cross-reactive_idiotype"_may_best_describe_the_specificity_of_the_Lc1_mAb._Also,_this_study_suggests_that_expression_of_CD5_may_delineate_categories_of_B_cell_SLL_that_differ_in_their_relative_rates_of_constitutive_Ig_V_gene_somatic_mutation.